Evidence map›Paper›PMID 35194959›Full record

ArticleCancer medicine2022

A systematic and comprehensive analysis of colorectal squamous cell carcinoma: Implication for diagnosis and treatment.

Yang Yang, Jiarui Yu, Jitao Hu, Chaoxi Zhou, Jian Niu, Hongqing Ma, Jiaxu Han, Shaoqing Fan, Youqiang Liu, Yalei Zhao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yang YangDepartment of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
Jiarui YuDepartment of Radiation Oncology, North China University of Science and Technology Affiliated People's Hospital, Tangshan, Hebei, China.
Jitao HuDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Chaoxi ZhouDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Jian NiuDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Hongqing MaDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Jiaxu HanDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Shaoqing FanDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Youqiang LiuDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yalei ZhaoDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Lianmei ZhaoResearch Centers, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.ORCID 0000-0002-9363-9588
Guiying WangDepartment of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.ORCID 0000-0001-9601-8210
Hebei Medical University · CNNorth China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was aimed at establishing a nomogram for survival prediction of Colorectal squamous cell carcinoma (CSCC), understanding the molecular pathogenesis, exploring a better treatment, and predicting the potential therapeutic agents.

methodsSurveillance, Epidemiology, and End Results (SEER) database was used to obtained CSCC patients and the nomogram was performed. Propensity score matching (PSM), Kaplan-Meier analysis, subgroup analysis, and interaction test were used to explore the better treatment strategy for CSCC. Bioinformatics were used to explore the molecular mechanism and potential therapeutic drugs of CSCC.

resultsA total of 3949 CSCC patients were studied. The nomogram was constructed and evaluated to have a good performance. We found that the radiotherapy had a better effect than surgery, and the difference between radiotherapy and combined therapy was not significant. 821 differentially expressed genes in CSCC were obtained from GSE6988 dataset. DNA damage repair, mismatch repair, and cell cycle pathways might contribute to CSCC occurrence as indicated by KEGGpathway and GSEA analysis. Transcription factors analysis revealed that TP63 and STAT1 may have an important role in occurrence and development of CSCC. 1607 potential drugs against CSCC were found using the CMAP database, and molecular docking was carried out to show the binding energy between TP63 and drugs.

conclusionsA good prognosis nomogram was constructed for CSCC. We also have a better understanding of the underlying molecular mechanisms of occurrence and development of CSCC and predicted potential therapeutic drugs, providing a theoretical basis for the treatment of CSCC.

Indexed as

Carcinoma, Squamous CellColorectal NeoplasmsHumansKaplan-Meier EstimateMolecular Docking SimulationNomogramscolorectal squamous cell carcinomadrug predictionmolecular mechanismnomogramtreatment strategy

Identifiers

PMID35194959
PMCPMC9189455
OpenAlexW4212769281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.